Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3
Yang-ling Li, Lin‐wen Wu, Linghui Zeng, et al.
Oncogene (2020) Vol. 39, Iss. 39, pp. 6203-6217
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
Xiaopei Hao, Zhiying Zheng, Hanyuan Liu, et al.
Redox Biology (2022) Vol. 56, pp. 102463-102463
Open Access | Times Cited: 172
Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway
Wei Zhang, Xiaoxiao Zheng, Yisong Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3209-3222
Open Access | Times Cited: 68
Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs
Kush K. Patel, Khosrow Kashfi
Biochemical Pharmacology (2021) Vol. 196, pp. 114654-114654
Open Access | Times Cited: 65
Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis
Liwen Ren, Jie Yi, Yihui Yang, et al.
Pharmacological Research (2022) Vol. 183, pp. 106376-106376
Closed Access | Times Cited: 59
Exosomes in the Diagnosis and Treatment of Renal Cell Cancer
Stergios Boussios, Perry Devo, Iain C. A. Goodall, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14356-14356
Open Access | Times Cited: 41
Current status of research on exosomes in general, and for the diagnosis and treatment of kidney cancer in particular
Weipu Mao, Keyi Wang, Zonglin Wu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 46
The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway
Hangyu Zhang, Yongfang Wang, Changgang Liu, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153746-153746
Closed Access | Times Cited: 33
Apolipoproteins: New players in cancers
Yingcheng He, Jianrui Chen, Yanbing Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Decoding the molecular landscape of keloids: new insights from single-cell transcriptomics
Yijun Xia, Youbin Wang, Mengjie Shan, et al.
Burns & Trauma (2023) Vol. 11
Open Access | Times Cited: 15
Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK/ERK and NF-κB pathway and suppress breast cancer growth and metastasis
Shaomin Liu, Fengqian Zhang, Yixia Liang, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2451-2465
Closed Access | Times Cited: 14
Seven Genes Involved in Cancer Metastasis
Mina Khajehdehi
IntechOpen eBooks (2025)
Closed Access
APOC1 expressed in macrophages promotes the pulmonary metastasis of colorectal cancer via CCL2/CCL5
Fei Qin, Haosheng Zheng, Jiayan Wu, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114611-114611
Closed Access
PCBP1 regulates the transcription and alternative splicing of metastasis‑related genes and pathways in hepatocellular carcinoma
Shuai Huang, Kai Luo, Li Jiang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 31
APOC1 promotes the progression of osteosarcoma by binding to MTCH2
Renjie Li, Huixian He, Xinxin He
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 12
APOC1 inhibit NKTCL doxorubicin sensitivity by promoting mitophagy
Sa Xiao, Jing Kuang, Jin‐Ji Yang, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access
Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy
Xinwei Li, Wei Xiong, Zhiyong Xiong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway
Jing Gao, Xiaojuan Lu, Guanglei Wang, et al.
Biomolecules and Biomedicine (2025)
Open Access
Free fatty acids derived from lipophagy enhanced resistance to anoikis by activating Src in high-invasive clear cell renal cell carcinoma cells
Mengmeng Wu, Guijuan Chen, Xin Li, et al.
Cellular Signalling (2025), pp. 111622-111622
Closed Access
APOC1, transcriptionally regulated by FOXM1, promotes M2 macrophage polarization and cervical cancer progression
Qing Chai, Yan Qi, Xiaoyan Nie, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2025) Vol. 830, pp. 111904-111904
Closed Access
Apolipoprotein C1 and apoprotein E as potential therapeutic and prognostic targets for adrenocortical carcinoma
Shaojin Li, Shuixiu Xiao, Yongli Situ
Cancer Biomarkers (2025) Vol. 42, Iss. 1
Closed Access
Exosomes in urological diseases - Biological functions and clinical applications
Qiang Song, Hao Yu, Jie Han, et al.
Cancer Letters (2022) Vol. 544, pp. 215809-215809
Open Access | Times Cited: 17
A unique regulated cell death-related classification regarding prognosis and immune landscapes in non-small cell lung cancer
Wei Su, Ting Hong, Baijie Feng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
<p>Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer</p>
Xiu Shi, Juan Wang, Shouqian Dai, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12881-12891
Open Access | Times Cited: 25
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3470-3470
Open Access | Times Cited: 21
DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD
Yang-ling Li, Man-man Zhang, Lin‐wen Wu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top